LQDA Earnings Date: Nov 2, 2026 (Estimated) — Liquidia Corporation
NASDAQ · Healthcare · Biotechnology
Updated
When is LQDA's next earnings date?
Liquidia Corporation (LQDA) is expected to report Q3 2026 earnings on Monday, November 2, 2026 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.96 on revenue of $214.2M.
How did LQDA do in its last earnings report?
In its most recent report on Aug 12, 2026 (Q2 2026), Liquidia Corporation posted EPS of $0.74 versus the $0.70 estimate, a beat of 8.6%. Revenue was $171.7M against a $168.5M estimate. The stock's 1-day post-earnings move was -10.5%.
How much does LQDA stock move after earnings?
LQDA beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 7.4% (up or down) in the day after earnings.
About Liquidia Corporation
Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 | Q2 2026 | 0.70 | 0.74 | -8.64% | $171.7M | ✅ Beat | -10.52% | -15.58% | -22.94% |
| 2026-05-11 | Q1 2026 | 0.39 | 0.52 | +33.33% | $132.9M | ✅ Beat | +25.60% | +34.59% | +51.32% |
| 2026-03-05 | Q4 2025 | 0.33 | 0.15 | -54.55% | $92.0M | ❌ Miss | +0.41% | +12.16% | +9.60% |
| 2025-11-03 | Q3 2025 | -0.38 | -0.04 | +89.47% | $54.3M | ✅ Beat | +3.53% | +7.10% | +26.40% |
| 2025-08-12 | Q2 2025 | -0.41 | -0.49 | -19.51% | $8.8M | ❌ Miss | +13.68% | +30.75% | +28.73% |
| 2025-05-08 | Q1 2025 | -0.42 | -0.45 | -7.14% | $3.1M | ❌ Miss | -1.16% | +20.09% | +16.81% |
| 2025-03-19 | Q4 2024 | -0.40 | -0.46 | -15.00% | $2.9M | ❌ Miss | +1.22% | +5.83% | -7.19% |
| 2024-11-13 | Q3 2024 | -0.37 | -0.39 | -5.41% | $4.4M | ❌ Miss | -3.39% | -4.42% | +3.57% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $171.7M total
| Segment | Share | Revenue | YoY | Q4 FY18 | Q2 FY19 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Product | 99.2% | $170.4M | +2514.4% | — | — | $6.5M | $51.7M |
| Service | 0.8% | $1.3M | -44.1% | — | — | $2.3M | $2.7M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.